A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder

Yukio Homma; Osamu Yamaguchi;

doi:10.1111/j.1442-2042.2009.02286.x

A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder

International Journal of Urology ◽

10.1111/j.1442-2042.2009.02286.x ◽

2009 ◽

Vol 16 (5) ◽

pp. 499-506 ◽

Cited By ~ 65

Author(s):

Yukio Homma ◽

Osamu Yamaguchi ◽

Keyword(s):

Overactive Bladder ◽

Controlled Trial ◽

Japanese Patients ◽

The Novel ◽

Antimuscarinic Agent ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder

BJU International ◽

10.1111/j.1464-410x.2007.07031.x ◽

2007 ◽

Vol 100 (3) ◽

pp. 579-587 ◽

Cited By ~ 76

Author(s):

Osamu Yamaguchi ◽

Eiji Marui ◽

Hidehiro Kakizaki ◽

Naoki Itoh ◽

Takashi Yokota ◽

...

Keyword(s):

Overactive Bladder ◽

Controlled Trial ◽

Japanese Patients ◽

Antimuscarinic Agent ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo

Download Full-text

Editorial Comment from Dr Dmochowski to Propiverine hydrochloride in Japanese patients with overactive bladder: A randomized, double-blind, placebo-controlled trial

International Journal of Urology ◽

10.1111/j.1442-2042.2011.02740.x ◽

2011 ◽

Vol 18 (5) ◽

pp. 374-374

Author(s):

Roger R Dmochowski

Keyword(s):

Overactive Bladder ◽

Editorial Comment ◽

Controlled Trial ◽

Japanese Patients ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

RANDOMIZED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF THE ONCE DAILY ANTIMUSCARINIC AGENT SOLIFENACIN SUCCINATE IN PATIENTS WITH OVERACTIVE BLADDER

The Journal of Urology ◽

10.1097/01.ju.0000140729.07840.16 ◽

2004 ◽

Vol 172 (5) ◽

pp. 1919-1924 ◽

Cited By ~ 237

Author(s):

L. CARDOZO ◽

M. LISEC ◽

R. MILLARD ◽

O. van VIERSSEN TRIP ◽

I. KUZMIN ◽

...

Keyword(s):

Overactive Bladder ◽

Controlled Trial ◽

Antimuscarinic Agent ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Solifenacin Succinate

Download Full-text

Propiverine hydrochloride in Japanese patients with overactive bladder: A randomized, double-blind, placebo-controlled trial

International Journal of Urology ◽

10.1111/j.1442-2042.2011.02732.x ◽

2011 ◽

Vol 18 (5) ◽

pp. 365-373 ◽

Cited By ~ 25

Author(s):

Momokazu Gotoh ◽

Osamu Yokoyama ◽

Osamu Nishizawa

Keyword(s):

Overactive Bladder ◽

Controlled Trial ◽

Japanese Patients ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Editorial Comment from Dr Sekido to Propiverine hydrochloride in Japanese patients with overactive bladder: A randomized, double-blind, placebo-controlled trial

International Journal of Urology ◽

10.1111/j.1442-2042.2011.02734.x ◽

2011 ◽

Vol 18 (5) ◽

pp. 373-374

Author(s):

Noritoshi Sekido

Keyword(s):

Overactive Bladder ◽

Editorial Comment ◽

Controlled Trial ◽

Japanese Patients ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

BJU International ◽

10.1111/j.1464-410x.2004.04606.x ◽

2004 ◽

Vol 93 (3) ◽

pp. 303-310 ◽

Cited By ~ 282

Author(s):

C.R. Chapple ◽

T. Rechberger ◽

S. Al-Shukri ◽

P. Meffan ◽

K. Everaert ◽

...

Keyword(s):

Overactive Bladder ◽

Controlled Trial ◽

Antimuscarinic Agent ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo

Download Full-text

A randomized, double-blind, placebo-controlled phase II dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder

International Journal of Urology ◽

10.1111/j.1442-2042.2008.02104.x ◽

2008 ◽

Vol 15 (9) ◽

pp. 809-815 ◽

Cited By ~ 32

Author(s):

Yukio Homma ◽

Takuhiro Yamaguchi ◽

Osamu Yamaguchi

Keyword(s):

Overactive Bladder ◽

Phase Ii ◽

Japanese Patients ◽

Dose Finding ◽

The Novel ◽

Double Blind ◽

Double Blind Placebo ◽

Finding Study ◽

Dose Finding Study

Download Full-text

Faculty Opinions recommendation of OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718006591.793478312 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder

Urology ◽

10.1016/j.urology.2009.09.018 ◽

2010 ◽

Vol 75 (1) ◽

pp. 62-68 ◽

Cited By ~ 63

Author(s):

Roger R. Dmochowski ◽

Kenneth M. Peters ◽

Jon D. Morrow ◽

Zhonghong Guan ◽

Jason Gong ◽

...

Keyword(s):

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Flexible Dose

Download Full-text

Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women

Phytomedicine ◽

10.1016/j.phymed.2012.10.007 ◽

2013 ◽

Vol 20 (3-4) ◽

pp. 351-358 ◽

Cited By ~ 11

Author(s):

Cornelia Betschart ◽

Ursula von Mandach ◽

Burkhardt Seifert ◽

David Scheiner ◽

Daniele Perucchini ◽

...

Keyword(s):

Overactive Bladder ◽

Postmenopausal Women ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Bryophyllum Pinnatum

Download Full-text